SPOTLIGHT: Big Pharma making big cuts

Johnson & Johnson is just one of many Pharma companies to announce big layoffs. In a company-wide restructuring, J&J said it would cut 4,800 jobs--and this was after 10,000 layoffs at Pfizer, 7,000 at Merck and 7,600 at AstraZeneca. The industry's been beleaguered by competition from generics and thin R&D pipelines, but some analysts blame Wall Street's unrealistic expectations for constant, double-digit earnings growth. Report

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.